M L Stefanelli studies conditions related to inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, as well as their relationships with other health issues like thyroid dysfunction and infections. They look at how these diseases manifest in patients and explore the implications of various treatments and medications on health. Stefanelli's research also extends to understanding the epidemiology of these diseases in specific populations, as well as potential complications from using common medications among vulnerable groups.
Key findings
In ulcerative colitis patients, certain tissue features like basal plasmacytosis and surface irregularity significantly raise relapse risk, with patients having these traits 2.98 to 4.50 times more likely to experience a relapse.
In San Marino, there are 241 cases of Crohn's disease and 311 cases of ulcerative colitis per 100,000 people, showing an increase in new cases over the last 35 years.
32% of patients with irritable bowel syndrome showed nodular lymphoid hyperplasia (NLH), indicating low-grade inflammation, compared to only 3% in those without symptoms.
In patients using analgesics and other drugs, the risk of kidney damage increased by 82% with blood clot preventers and 37% with ulcer medications.
64.7% of participants in a study from San Marino had been exposed to hepatitis A, with increasing exposure rates from 28.6% in younger adults to 97% in older adults.
Frequently asked questions
Does M L Stefanelli study ulcerative colitis?
Yes, M L Stefanelli conducts research on ulcerative colitis, focusing on disease mechanisms and the risk of relapse.
What specific conditions does M L Stefanelli focus on?
M L Stefanelli focuses primarily on inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, along with conditions such as irritable bowel syndrome and complications from medication use.
Is M L Stefanelli's work relevant to patients taking pain medications?
Yes, their research highlights the risks associated with commonly prescribed pain medications and their potential to cause organ damage, especially in elderly patients.
What is the significance of M L Stefanelli's study on hepatitis A?
The research provides evidence of high exposure rates to hepatitis A in San Marino, stressing the need for vaccination and education, particularly among younger adults.
How can M L Stefanelli's findings help my doctor?
Their findings can help doctors understand better diagnostic markers for inflammatory bowel diseases and make safer medication choices for their patients.
Publications in plain English
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis.
2024
Journal of personalized medicine
Laterza L, Piscaglia AC, Bibbò S, Arena V, Brisigotti M +12 more
Plain English This study looked at patients with ulcerative colitis who appeared to have healed mucosal tissue but still had signs of ongoing disease activity in their tissue samples. Out of 100 patients, only 2 showed no remaining signs of disease. The research found that certain conditions in the tissue, like basal plasmacytosis and surface irregularity, were linked to a higher chance of the disease coming back; specifically, patients with these features were 2.98 to 4.50 times more likely to relapse.
Who this helps: This helps patients with ulcerative colitis and their doctors by identifying risks for disease reactivation.
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study.
2019
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Piscaglia AC, Lopetuso LR, Laterza L, Gerardi V, Sacchini E +5 more
Plain English This study looked at the rates of Crohn's disease and ulcerative colitis in San Marino over the past 35 years. It found that as of 2014, there were 241 cases of Crohn's disease and 311 cases of ulcerative colitis per 100,000 people, with both diseases showing a significant increase in new cases over the decades. Understanding these trends is important because it helps identify health needs and guide treatment in this small nation.
Who this helps: Patients living with inflammatory bowel disease and their healthcare providers.
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature.
2016
European review for medical and pharmacological sciences
Laterza L, Piscaglia AC, Lecce S, Gasbarrini A, Stefanelli ML
Plain English This study looked at a 38-year-old woman who developed ulcerative colitis following a serious episode of thyroid overactivity (thyrotoxicosis) related to a condition called Graves' disease. After experiencing three crises related to her thyroid, she was diagnosed with ulcerative colitis, suggesting that her thyroid problems may have triggered this intestinal disease. Understanding this link helps doctors better recognize the potential risks for patients with thyroid dysfunctions.
Who this helps: This helps patients with thyroid issues and their doctors in monitoring for possible gastrointestinal problems.
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
2016
World journal of gastroenterology
Piscaglia AC, Laterza L, Cesario V, Gerardi V, Landi R +6 more
Plain English This study looked at the presence of nodular lymphoid hyperplasia (NLH) in patients undergoing colonoscopy and how it relates to conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Researchers found that NLH was present in 32% of patients with IBS symptoms, compared to only 3% in those without symptoms, suggesting that it may indicate low-grade inflammation in these patients. This finding is significant because it could help doctors better understand and manage patients with IBS who have this inflammation.
Who this helps: Patients with irritable bowel syndrome and their healthcare providers.
Analgesic, antiulcer, antithrombotic drugs and organ damage: a population-based case-control study.
2015
Minerva medica
Battelli D, Riccardi R, Piscaglia AC, Stefanelli ML, Mussoni L +3 more
Plain English This study looked at how commonly painkillers (NSAIDs), ulcer medications (AUDs), and blood clot preventers (ATDs) are used by older people with organ damage to the digestive system, heart, or kidneys. It found that while ulcer medications seemed to lower the risk of stomach damage, NSAIDs and ATDs increased the risk of kidney problems. Specifically, using ATDs raised the risk of kidney damage by 82% and using AUDs increased it by 37%. This matters because it highlights the risks of combining these common medications in elderly patients who are already vulnerable to organ damage.
Who this helps: This research helps doctors prescribe safer medication combinations for elderly patients.
Chronic anisakidosis presenting with intestinal intussusception.
2014
European review for medical and pharmacological sciences
Piscaglia AC, Ventura MT, Landolfo G, Giordano M, Russo S +4 more
Plain English This study looked at a unique case of a 52-year-old woman who developed a parasitic infection from eating raw or undercooked fish. She experienced severe abdominal pain and vomiting due to a blockage in her intestines, which was caused by the Anisakis parasite. After surgery, doctors confirmed the presence of this parasite in her intestinal wall, highlighting the potential severity of anisakidosis, especially in patients with weakened immune systems.
Who this helps: This helps patients who eat raw fish and may be at risk for parasitic infections, as well as doctors treating similar cases.
Effect of Helicobacter pylori infection, age and epithelial cell turnover in a general population at high risk for gastric cancer.
1999
Panminerva medica
Baldini L, Pretolani S, Bonvicini F, Miglio F, Epifanio G +4 more
Plain English This study looked at how the infection with Helicobacter pylori (H. pylori), age, and cell turnover in the stomach might relate to the risk of developing gastric cancer. Researchers found that 82% of people with H. pylori had atrophic gastritis compared to only 17.6% of those without the infection. This matters because having atrophic gastritis and high cell turnover can increase the risk of gastric cancer, which is especially concerning in populations where rates of the disease are already high.
Who this helps: This study helps doctors and patients, particularly those at high risk for gastric cancer.
Population-based survey of hepatitis A virus infection in the Republic of San Marino.
1997
European journal of epidemiology
Stroffolini T, Pretolani S, Miglio F, Rapicetta M, Villano U +9 more
Plain English In a study conducted in San Marino, researchers tested 1,528 healthy people aged 20 to 85 for hepatitis A virus antibodies. They found that 64.7% of participants had been exposed to the virus, with exposure increasing significantly from 28.6% in younger adults (20-30 years) to 97% in older adults (over 60 years). This is important because it highlights that many younger adults are becoming non-immune to hepatitis A, which could lead to more cases of the disease in the future.
Who this helps: This benefits public health officials and healthcare providers who can focus on vaccination and education for younger populations.
Seroprevalence of hepatitis A virus and Helicobacter pylori infections in the general population of a developed European country (the San Marino study): evidence for similar pattern of spread.
1997
European journal of gastroenterology & hepatology
Pretolani S, Stroffolini T, Rapicetta M, Bonvicini F, Baldini L +10 more
Plain English This study looked at how hepatitis A virus and Helicobacter pylori (H. pylori) infections are spread in the Republic of San Marino. Researchers examined blood samples from 1,528 healthy people and found that 78.9% of those with H. pylori also had hepatitis A, compared to just 53.6% of those without H. pylori. This pattern suggests that both infections may spread in similar ways, highlighting a connection between them that could help in understanding and preventing these diseases.
Who this helps: This benefits public health officials and healthcare providers working on infection control.